US Pharma MarketingEli Lilly cracks down on illicit weight loss drug trade with US lawsuits
Eli Lilly cracks down on illicit weight loss drug trade with US lawsuits is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Eli Lilly is suing several US companies that are allegedly selling illegal versions of its weight loss candidate, retatrutide.
Source: Pharmaceutical Technology